Published in the web American Journal of Geriatric Psychiatry.

Antidepressant citalopram displays promise in treating symptoms of dementia Researchers have got found surprising evidence an antidepressant might perform as well as a commonly-prescribed antipsychotic in the alleviation of severe agitation and psychotic symptoms of dementia. The study, published in the web American Journal of Geriatric Psychiatry , is believed to be the initial head-to-head assessment of an SSRI with one of the more commonly prescribed second generation antipsychotics in older, non-depressed patients. The findings are exciting because they raise the possibility of a fresh direction in medications for psychotic disorders linked to dementia in older people approved by fda .

Prof Chris Kennard, chairman of the MRC’s Neuroscience and Mental Health Plank, which funded the research, said: The Medical Study Council invests in cohort studies like CFAS because they provide vital clinical details through observation. Such tasks require long-term commitment to fulfil their potential but having backed cohort studies for more than half a century, MRC collaborations and financing have made the united kingdom an international leader in this field. A combined group of scientists led by the Regenstrief Institute in Indianapolis, US, supported by scientists from Norwich Medical College at UEA, and the NHS, developed the AntiCholinergic Burden level ( Dr Malaz Boustani, Associate Professor of Medicine at Indiana University, who evaluations the huge benefits and harms of these medications with sufferers at the Wishard Healthful Aging Brain Center in Indianapolis, stated: Our findings inform you that clinicians have to review the cumulative anticholinergic burden in people presenting with cognitive impairment to determine if the medicines are causing decline in mental position.